Contact this trialFirst, we need to learn more about you.
CFTR Modulator
VX-121 Combination Therapy for Cystic Fibrosis
Recruiting1 awardPhase 3
Buffalo, New York
This trial will test the efficacy and safety of VX-121/tezacaftor/deutivacaftor in CF patients who have one F508del mutation and one minimal function mutation.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.